Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study
Background: The autoimmune profile of Chronic Urticaria (CU) patients is an increasing topic of interest. Associated diseases suggest shared pathogenic pathways, and they may provide important knowledge on specific targets for future treatment models. In this study we examined the prevalence and ris...
Main Authors: | Misbah Noshela Ghazanfar, Line Kibsgaard, Simon Francis Thomsen, Christian Vestergaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119312530 |
Similar Items
-
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
by: Misbah Noshela Ghazanfar, et al.
Published: (2018-10-01) -
Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies
by: Misbah Nasheela Ghazanfar, et al.
Published: (2015-01-01) -
Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
by: Rikke Bech, et al.
Published: (2018-09-01) -
Why a registry of Chronic Urticaria (CUR) is needed
by: R. M. Gómez, et al.
Published: (2017-05-01) -
Why a registry of Chronic Urticaria (CUR) is needed
by: R.M. Gómez, et al.
Published: (2017-01-01)